Androgen Deprivation Therapy (ADT) Market : Facts, Figures and Analytical Insights –

Androgen deprivation therapy (ADT) is a type of antihormone therapy which is primarily utilized in the cure of prostate cancer. Prostate cancer cells typically requires androgen hormones such as testosterone to grow. The use of androgen deprivation therapy reduces the level of androgen hormones, with surgery or drug delivery to prevent the prostate cells from rising. Various studies have determined that ADT has shown the benefits in patients with metastatic disease, and as an addition to radiation therapy in patients with locally developed disease, including those with adverse intermediate-risk or extreme-risk localized disease. Surging incidences of prostate cancer, rising male geriatric population, along with increasing government efforts to implement & conduct programs for creating of awareness of screening tests such as Prostate-Specific Antigen (PSA) blood tests are the few factor responsible for high CAGR of the market over the forecast period. For instance, according to the GLOBOCAN 2018 estimates in 2018, about 1,276,106 new cases of prostate cancer were registered worldwide, representing 7.1% of all cancers in men. Similarly, As per the Canadian Cancer Society, it is estimated that 22,900 men will be diagnosed with prostate cancer in 2019 and this represents 20% of all new cancer cases in men in 2019. Moreover, technological advancement in screening & diagnostic tests is one of the major factor projected to create lucrative growth opportunities to the market growth in the forecasting years. However, side effects associated with ADT is the major factor restraining the growth of global Androgen Deprivation Therapy (ADT) market during the forecast period of 2019-2026.

Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10265685

The regional analysis of global Androgen Deprivation Therapy (ADT) Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the surging investments in R&D for the development of newer immunotherapies and targeted drug therapies to treat prostate cancer in the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period due to rising awareness among patient towards the treatment of prostate cancer. Further, increasing number of government programs to promote the adoption of ADT, would also create a lucrative opportunity for the growth of the market in the Asia-Pacific region.

 Market player included in this report are::
Pfizer Inc.
Astellas Pharma Inc.
Johnson & Johnson
Novartis International AG
Veru Inc.
Sanofi S.A.
GlaxoSmithKline plc
Bayer AG
Orion Corporation
AstraZeneca Plc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:
Antiandrogens
LHRH Agonists
LHRH Antagonist
Others


By Route of Administration:
Oral
Injectable


By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Read More: https://www.kennethresearch.com/report-details/androgen-deprivation-therapy-adt-market/10265685

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Androgen Deprivation Therapy (ADT) Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10265685

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Androgen Deprivation Therapy (ADT) Market, by Drug Class, 2017-2026 (USD Billion)
1.2.2. Androgen Deprivation Therapy (ADT) Market, by Route of Administration, 2017-2026 (USD Billion)
1.2.3. Androgen Deprivation Therapy (ADT) Market, by Distribution Channel, 2017-2026 (USD Billion)
1.2.4. Androgen Deprivation Therapy (ADT) Market, by Region, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Androgen Deprivation Therapy (ADT) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Androgen Deprivation Therapy (ADT) Market Dynamics
3.1. Androgen Deprivation Therapy (ADT) Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Androgen Deprivation Therapy (ADT) Market Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Androgen Deprivation Therapy (ADT) Market, by Drug Class
5.1. Market Snapshot
5.2. Global Androgen Deprivation Therapy (ADT) Market by Drug Class, Performance – Potential Analysis
5.3. Global Androgen Deprivation Therapy (ADT) Market Estimates & Forecasts by Drug Class 2016-2026 (USD Billion)

About Kenneth Research:
Kenneth Research is a reselling agency which focuses on multi-client market research database. The primary goal of the agency is to help industry professionals including various individuals and organizations gain an extra edge of competitiveness and help them identify the market trends and scope. The quality reports provided by the agency aims to make decision making easier for industry professionals and take firm decisions which helps them to form strategies after complete assessment of the market. Some of the industries under focus include healthcare & pharmaceuticals, ICT & Telecom, automotive and transportation, energy and power, chemicals, FMCG, food and beverages, aerospace and defense and others. Kenneth Research also focuses on strategic business consultancy services and offers a single platform for the best industry market research reports.

Contact Us
Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 1072

Eli is a freelance writer and possess double graduation degree in physics and chemistry. She is an intense writer covering everything for Science and Tech to Business, Entertainment, Sports and Lifestyle.

Leave a Reply